Vanguard Group
LEGN icon

Vanguard Group’s Legend Biotech LEGN Stock Holding History

Vanguard Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.25M Buy
149,619
+12,022
+9% +$344K ﹤0.01% 3408
2025
Q3 		$4.49M Buy
137,597
+15,565
+13% +$575K ﹤0.01% 3313
2025
Q2 		$4.33M Sell
122,032
-13,474
-10% -$437K ﹤0.01% 3258
2025
Q1 		$4.6M Buy
135,506
+7,013
+5% +$252K ﹤0.01% 3208
2024
Q4 		$4.18M Buy
128,493
+4,754
+4% +$197K ﹤0.01% 3339
2024
Q3 		$6.03M Hold
123,739
– – ﹤0.01% 3190
2024
Q2 		$5.48M Sell
123,739
-5,620
-4% -$259K ﹤0.01% 3222
2024
Q1 		$7.26M Buy
129,359
+738
+0.6% +$44.5K ﹤0.01% 3133
2023
Q4 		$7.74M Buy
128,621
+13,821
+12% +$876K ﹤0.01% 3087
2023
Q3 		$7.71M Hold
114,800
– – ﹤0.01% 3044
2023
Q2 		$7.92M Sell
114,800
-833
-0.7% -$54.4K ﹤0.01% 3075
2023
Q1 		$5.58M Buy
115,633
+27,649
+31% +$1.35M ﹤0.01% 3251
2022
Q4 		$4.39M Hold
87,984
– – ﹤0.01% 3363
2022
Q3 		$3.59M Buy
87,984
+4,458
+5% +$209K ﹤0.01% 3495
2022
Q2 		$4.59M Buy
83,526
+5,710
+7% +$241K ﹤0.01% 3421
2022
Q1 		$2.83M Hold
77,816
– – ﹤0.01% 3805
2021
Q4 		$3.63M Buy
+77,816
New +$3.95M ﹤0.01% 3786

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Group's LEGN Position: Q4 2025 in Review

Vanguard Group increased its Legend Biotech (LEGN) stake by 8.7% in Q4 2025, buying an estimated $344K and bringing the position to 149,619 shares worth $3.25M. The position accounts for ﹤0.01% of the portfolio, ranked #3408.

Vanguard Group first reported a position in LEGN in Q4 2021 and has held it in 17 quarters since. The position peaked at $7.92M in Q2 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q4 2025.

  • Vanguard Group held 149,619 shares of Legend Biotech worth $3.25M as of Q4 2025.
  • Vanguard Group bought 12,022 Legend Biotech shares in Q4 2025, an estimated $344K.
  • Legend Biotech made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3408 holding.
  • Vanguard Group first reported a position in Legend Biotech in Q4 2021 and has held it in 17 quarters since.
  • Vanguard Group's Legend Biotech position peaked at $7.92M in Q2 2023.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.